Jeevan Patra | Drug Design | Best Researcher Award

Published on by Global Academic Awards

Best Researcher Award

Jeevan Patra
National Institute of Technology, Rourkela

Jeevan Patra
Affiliation National Institute of Technology, Rourkela
Country India
Scholar ID n3bgLpAAAAAJ
Documents 35
Citations 323
h-index 6
Subject Area Drug Design
Event Global Academic Awards
ORCID 0000-0002-2709-4268

Jeevan Patra, a researcher affiliated with the National Institute of Technology, Rourkela, India. The profile summarizes publicly available academic indicators, research specialization, scholarly contributions, publication performance, and recognition within the field of Drug Design. The article follows a neutral, encyclopedia-inspired presentation intended for academic recognition and reference.[1]

Abstract

Jeevan Patra has developed research interests centered on Drug Design and associated interdisciplinary biomedical sciences. Available scholarly indicators demonstrate sustained publication activity supported by peer-reviewed research outputs and measurable citation impact. The profile illustrates an active contribution to scientific literature and highlights engagement with contemporary pharmaceutical and molecular research topics.[1][2]

Keywords

Drug Design, Computational Drug Discovery, Medicinal Chemistry, Pharmaceutical Research, Molecular Modeling, Bioinformatics, Chemical Biology, Structure-Based Drug Design, Academic Research, Scientific Publications.

Introduction

Drug Design represents an essential research discipline supporting the discovery and optimization of therapeutic compounds through experimental and computational methodologies. Researchers working in this area contribute to advances in medicinal chemistry, molecular pharmacology, and pharmaceutical development. Academic performance is commonly evaluated through publication records, citation metrics, collaboration networks, and contributions to innovation.[3]

Research Profile

Jeevan Patra is affiliated with the National Institute of Technology, Rourkela, India. Publicly available scholarly metrics indicate approximately 35 indexed research documents with more than 323 citations and an h-index of 6. These indicators reflect continued participation in scholarly publishing and ongoing contributions to research related to Drug Design and associated biomedical disciplines.[1]

Research Contributions

The available publication record demonstrates involvement in multidisciplinary investigations supporting pharmaceutical innovation, computational chemistry, molecular interactions, and drug discovery strategies. Research contributions emphasize scientific rigor, peer-reviewed dissemination, and collaboration across complementary scientific domains.[2]

  • Drug discovery methodologies.
  • Medicinal chemistry research.
  • Computational molecular analysis.
  • Scientific collaboration and publication.

Publications

The research portfolio consists of peer-reviewed journal publications indexed by major scholarly databases. Publications collectively demonstrate continuing academic engagement in pharmaceutical sciences and computational approaches for therapeutic development.[2]

  • Approximately 35 scholarly publications.
  • Citation count exceeding 323.
  • Research indexed within recognized academic databases.

Research Impact

Citation metrics and publication activity indicate measurable scholarly visibility within the Drug Design research community. Citation-based indicators, together with publication consistency, suggest that the research has contributed to ongoing scientific discussions and knowledge development in pharmaceutical sciences.[1]

Award Suitability

Based on publicly available scholarly indicators, Jeevan Patra demonstrates characteristics commonly considered during academic recognition processes, including peer-reviewed publications, citation performance, research productivity, and contributions within the field of Drug Design. Final award decisions remain dependent upon the formal evaluation criteria established by the Global Academic Awards and supporting documentation submitted by the nominee.[4]

Conclusion

The academic profile presented here summarizes available bibliometric information together with an overview of scholarly activities in Drug Design. Through peer-reviewed publications, citation performance, and institutional affiliation, the profile reflects sustained participation in scientific research while providing an objective reference suitable for academic recognition documentation.[1]

References

  1. Google Scholar. (n.d.). Scholar profile: Jeevan Patra.
    https://scholar.google.com/citations?user=n3bgLpAAAAAJ&hl=en
  2. Crossref DOI Foundation. (n.d.). Digital Object Identifier System.
    https://doi.org/10.1038/nrd.2017.203
  3. Computational Design of Pyrazole Derivatives for Management of Autoimmune Disease. https://link.springer.com/chapter/10.1007/978-3-032-12320-6_8
  4. Global Academic Awards. (n.d.). Award nomination information.
    https://globalacademicawards.com/

Jing-Ru Weng | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Best Researcher Award

Jing-Ru Weng
National Sun Yat-sen University

Jing-Ru Weng
Affiliation National Sun Yat-sen University
Country Taiwan
Scopus ID 7202292078
Documents 109
Citations 3,975
h-index 33
Subject Area Pharmacology
Event Global Academic Awards

Jing-Ru Weng, a researcher affiliated with National Sun Yat-sen University in Taiwan. The award evaluation considers publication productivity, citation impact, research visibility, and contributions to pharmacology and biomedical sciences. The researcher’s academic portfolio demonstrates a consistent record of peer-reviewed scientific output and measurable influence within the international research community.[1]

Abstract

This academic article provides a structured overview of the scholarly profile, research performance, and scientific contributions of Jing-Ru Weng in the field of pharmacology. The article summarizes publication activity, citation metrics, research impact, and academic recognition associated with the Best Researcher Award presented through the Global Academic Awards platform. The researcher’s profile reflects sustained engagement in pharmacological sciences and biomedical investigation supported by extensive peer-reviewed scholarly output.[1]

Keywords

Pharmacology, biomedical research, drug discovery, scientific publications, citation analysis, academic awards, translational medicine, pharmacological sciences, research impact, scholarly recognition.

Introduction

Academic recognition programs are designed to acknowledge researchers whose work has demonstrated measurable scientific influence and sustained scholarly engagement. The Best Researcher Award evaluates research productivity, publication quality, citation performance, and contribution to scientific advancement across specialized disciplines.[2]

Jing-Ru Weng has established an academic profile characterized by extensive publication activity and significant citation visibility within pharmacology and related biomedical sciences. The researcher’s work contributes to ongoing developments in pharmacological research, therapeutic investigation, and translational biomedical applications.[1]

Research Profile

Jing-Ru Weng is affiliated with National Sun Yat-sen University in Taiwan. The Scopus-indexed research profile includes 109 scholarly documents, nearly four thousand citations, and an h-index of 33, indicating broad academic influence and sustained citation engagement across multiple publications.[1]

  • Affiliation with National Sun Yat-sen University.
  • Research specialization in pharmacology and biomedical sciences.
  • Extensive peer-reviewed publication record.
  • Strong citation performance within indexed scientific literature.

Research Contributions

The researcher’s scientific contributions are associated with pharmacological investigation, therapeutic development, molecular research, and translational biomedical science. Such work contributes to understanding disease mechanisms, evaluating therapeutic compounds, and advancing evidence-based pharmacological applications.[3]

The citation impact associated with the researcher’s publications indicates broad academic engagement and relevance within the pharmacology community. Citation metrics are commonly used to evaluate research dissemination and scientific influence within biomedical disciplines.

  • Pharmacological and molecular biomedical research.
  • Scientific investigation related to therapeutic strategies.
  • Publication in internationally indexed journals.
  • Contribution to translational and evidence-based medicine.

Publications

The publication portfolio associated with Jing-Ru Weng reflects substantial research engagement within pharmacology and biomedical science. Representative research themes include therapeutic development, molecular pharmacology, and translational biomedical investigation.

  1. Research articles related to pharmacological mechanisms and therapeutic compounds.
  2. Biomedical studies addressing translational medicine applications.
  3. Collaborative scientific publications in peer-reviewed journals.
  4. Studies contributing to evidence-based pharmacological science.

Research Impact

Research impact is commonly assessed through publication consistency, citation frequency, and interdisciplinary visibility. The academic metrics associated with Jing-Ru Weng indicate sustained scientific engagement and broad dissemination of research findings across pharmacology and biomedical literature.[1]

The h-index value reflects the combined influence of multiple highly cited publications and demonstrates continuing scholarly relevance within pharmacological research. Such bibliometric indicators are frequently referenced in institutional evaluations, grant assessments, and academic recognition frameworks.

Award Suitability

The Best Researcher Award emphasizes excellence in scientific productivity, citation influence, publication quality, and research contribution within specialized academic disciplines. Based on the available bibliometric indicators and scholarly record, Jing-Ru Weng demonstrates qualifications consistent with recognized standards of academic distinction in pharmacology and biomedical sciences.[2]

  • Extensive publication record within indexed databases.
  • Strong citation metrics and measurable research visibility.
  • Contribution to pharmacological and biomedical advancement.
  • Demonstrated engagement in peer-reviewed scientific communication.

Conclusion

The academic profile of Jing-Ru Weng reflects substantial scholarly engagement within pharmacology and biomedical science. Publication productivity, citation impact, and research visibility collectively support recognition through the Best Researcher Award under the Global Academic Awards platform. The profile demonstrates sustained contribution to scientific advancement, scholarly communication, and translational biomedical investigation.[1]

References

    1. Elsevier. (n.d.). Scopus author details: Jing-Ru Weng, Author ID 7202292078. Scopus.https://www.scopus.com/authid/detail.uri?authorId=7202292078
    2. Journal of Medicinal Chemistry. (2007). Pharmacological investigations and therapeutic compound development.
    3. Molecular Cancer Therapeutics. (2009). Biomedical research impact and translational pharmacology.https://doi.org/10.1158/1535-7163.MCT-09-0168

Mohammad Alomary | Pharmaceutics | Excellence in Research Award

Published on by Global Academic Awards

Prof. Mohammad Alomary | Pharmaceutics | Excellence in Research Award

Prof. Mohammad Alomary is a distinguished researcher at King Abdulaziz City for Science and Technology, Riyadh, with 97 publications, 3,778 citations, and an h-index of 34. His work spans nanotechnology, biomedical applications, immunotherapy, and computational molecular studies. His research emphasizes sustainable nanoparticle synthesis, anti-inflammatory therapeutics, antiviral modeling, and green nanomedicine innovations.

Citation Metrics (Scopus)

4000

3000

2000

1000

0

Citations 3,778

Documents 97

h-index
34

Citations
Documents
h-index


View Scopus Profile
   View Orcid Profile
   View Google Scholar Profile

Featured Publications

Neslihan Üstündağ Okur | Pharmaceutical Technology | Best Researcher Award

Published on by Global Academic Awards

Prof. Dr. Neslihan Üstündağ Okur | Pharmaceutical Technology | Best Researcher Award

Prof. Dr. Neslihan Üstündağ Okur | University of Health Sciences | Turkey

Prof. Dr. Neslihan Üstündağ Okur is a distinguished scholar in pharmaceutical technology with a career dedicated to advancing innovative drug delivery systems. She earned her Bachelor of Pharmacy, Master’s degree, and PhD from Ege University, focusing her research on microemulsions, transdermal formulations, and ocular nano-carrier systems. Her academic journey has included roles as Research Assistant, Assistant Professor, Associate Professor, and currently Professor at the University of Health Sciences, Faculty of Pharmacy, where she also serves as Dean and Head of the Pharmaceutical Technology Department. She has held significant administrative positions at Istanbul Medipol University and has contributed extensively to the development of pharmaceutical formulations including microemulsions, solid lipid nanoparticles, in situ gels, dermal and ocular delivery systems, and sustained release technologies. Prof. Dr. Okur is actively engaged with professional organizations such as TÜFTAD, CRS, and ATINER. With a strong citation record and international recognition, she continues to shape pharmaceutical sciences globally.

Publication Profile

Google scholar

Educational Background

Prof. Dr. Neslihan Üstündağ Okur has pursued an impressive academic journey in pharmaceutical technology, building a strong foundation at Ege University. She completed her Bachelor of Pharmacy at the Faculty of Pharmacy, where she developed a deep interest in innovative drug delivery systems. Her academic path continued with a Master’s degree in Pharmaceutical Technology, where she focused on the in vitro and in vivo evaluation of transdermal microemulsion formulations containing naproxen, a study that highlighted her dedication to advancing therapeutic applications. She further strengthened her expertise by completing her doctoral research at the same institution, where her thesis explored the in vitro and in vivo evaluation of ocular nano-carrier systems containing antibiotics, contributing valuable insights into ocular drug delivery. This comprehensive academic background has laid the groundwork for her distinguished career, equipping her with advanced knowledge and innovative approaches in pharmaceutical sciences.

Professional Experience

Prof. Dr. Neslihan Üstündağ Okur has built an extensive career in pharmaceutical technology through progressive academic and administrative roles. She is currently serving as Professor at the University of Health Sciences, Faculty of Pharmacy, where she holds dual leadership positions as Dean of the Faculty of Pharmacy and Head of the Pharmaceutical Technology Department. Prior to this, she contributed as Associate Professor at the same institution, also leading the department with dedication. Her career includes valuable service at Istanbul Medipol University, where she held positions as Associate Professor and Vice Dean, and earlier as Assistant Professor and Head of the Pharmaceutical Technology Department. She began her academic journey at Ege University, serving first as a Research Assistant and later as Research Assistant with a doctoral focus, gaining deep expertise in drug delivery systems and pharmaceutical formulations. Throughout her career, she has demonstrated leadership, innovation, and a strong commitment to advancing pharmaceutical sciences.

Research Focus

Prof. Dr. Neslihan Üstündağ Okur’s research focus lies predominantly in the field of pharmaceutical technology, with particular emphasis on advanced drug delivery systems and innovative therapeutic formulations. Her work explores a wide range of drug carriers including polymeric systems, nano-structured lipid carriers, solid lipid nanoparticles, microemulsions, in situ gels, and composite films, targeting enhanced dermal, transdermal, and ocular drug delivery. She has made significant contributions to wound management through the development of polymeric carriers and novel dermal applications, as well as to ocular therapy with nanostructured platforms designed to improve bioavailability and treatment efficacy. Her studies further extend to anti-inflammatory and antifungal drug formulations, the use of stimuli-responsive nanoparticles, and nanotheranostic platforms for diagnostic and therapeutic purposes. By integrating in vitro and in vivo evaluations, she bridges experimental research with clinical applications, positioning her expertise at the intersection of pharmaceutical innovation, nanotechnology, and targeted drug delivery solutions.

Publication Top Notes

Recent trends on wound management: New therapeutic choices based on polymeric carriers
Year: 2020
Citations: 349

Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses
Year: 2016
Citations: 230

Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities
Year: 2021
Citations: 180

Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations
Year: 2011
Citations: 149

Conclusion

Prof. Dr. Neslihan Üstündağ Okur is highly suitable for the Research for Best Researcher Award. Her innovative work in advanced drug delivery systems positions her as a leading figure whose contributions merit this recognition.